DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Arhalofenate is an investigational drug.
There have been 5 clinical trials for Arhalofenate. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2014.
The most common disease conditions in clinical trials are Gout, Hyperuricemia, and [disabled in preview]. The leading clinical trial sponsors are CymaBay Therapeutics, Inc. and [disabled in preview].
There are eight US patents protecting this investigational drug and one international patent.
Recent Clinical Trials for Arhalofenate
|Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout||CymaBay Therapeutics, Inc.||Phase 2|
|Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients||CymaBay Therapeutics, Inc.||Phase 2|
|Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients||CymaBay Therapeutics, Inc.||Phase 2|
Top disease conditions for Arhalofenate
Top clinical trial sponsors for Arhalofenate
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Arhalofenate||Start Trial||Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent||CymaBay Therapeutics, Inc. (Newark, CA) DiaTex, Inc. (San Antonio, TX)||Start Trial|
|Arhalofenate||Start Trial||Process for the preparation of (-)-(4-chloro-phenyl)-(3-trifluoromethyl-phenoxy)-acetic acid 2-acetylamino-ethyl ester||Metabolex, Inc. (Hayward, CA)||Start Trial|
|Arhalofenate||Start Trial||DCC mediated coupling for halofenate manufacture||Cymabay Therapeutics, Inc. (Newark, CA)||Start Trial|
|Arhalofenate||Start Trial||Methods for treating hyperuricemia in patients with gout using halofenate or halogenic acid and a second urate-lowering agent||Cymabay Therapeutics, Inc. (Newark, CA)||Start Trial|
|Arhalofenate||Start Trial||Methods for treating gout flares||CYMABAY THERAPEUTICS, INC. (Newark, CA)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|